A Comparative Study of Salvage Treatment With Combination of Docetaxel and Epirubicin.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Docetaxel (Primary) ; Epirubicin (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 17 Aug 2016 Biomarkers information updated
- 26 Jun 2012 New trial record